Stimcell Energetics (STME) Gross Profit (QoQ) (2016 - 2023)
Stimcell Energetics (STME) Gross Profit (QoQ) (2016 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -166.24% |
| Feb 28, 2023 | 35.69% |
| Nov 30, 2022 | 286.48% |
| Aug 31, 2022 | -112.55% |
| May 31, 2022 | 1,864.04% |
| Feb 28, 2022 | -85.89% |
| Nov 30, 2021 | -7.34% |
| Aug 31, 2021 | 786.61% |
| May 31, 2021 | -107.61% |
| Feb 28, 2021 | 88.90% |
| Nov 30, 2020 | -19.58% |
| Aug 31, 2020 | -97.96% |
| May 31, 2020 | 658.17% |
| Feb 29, 2020 | -26.90% |
| Nov 30, 2019 | -34.91% |
| Feb 28, 2017 | -64.10% |
| Nov 30, 2016 | -92.03% |
| Aug 31, 2016 | -63.26% |
| May 31, 2016 | 320.44% |